WEST PHARMACEUTICAL SERVICES, INC. Fair Value of Long-Term Debt
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Fair Value of Long-Term Debt of $202.40 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2026-02-17
- 2025-12-31: Long-term Debt, Fair Value $202.40M.
- 2024-12-31: Long-term Debt, Fair Value $200.50M.
- 2024-03-31: Long-term Debt, Fair Value $70.30M.
- 2023-12-31: Long-term Debt, Fair Value $70.80M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2025-12-31 | $202.40M 10-K · filed 2026-02-17 |
| 2024-12-31 | $200.50M 10-K · filed 2025-02-18 |
| 2024-03-31 | $70.30M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $70.80M 10-Q · filed 2024-04-25 |
| 2023-09-30 | $147.20M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $201.10M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $201.20M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $201.80M 10-K · filed 2024-02-20 |
| 2022-09-30 | $202.20M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $206.00M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $210.40M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $217.90M 10-K · filed 2023-02-21 |
| 2021-09-30 | $220.30M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $263.90M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $264.60M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $265.70M 10-K · filed 2022-02-22 |
| 2020-09-30 | $266.40M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $267.20M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $260.80M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $263.30M 10-K · filed 2021-02-23 |
| 2019-09-30 | $204.40M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $203.20M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $197.40M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $192.60M 10-K · filed 2020-02-24 |
| 2018-09-30 | $192.50M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $194.60M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $198.60M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $201.50M 10-K · filed 2019-02-28 |
| 2017-09-30 | $201.00M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $199.30M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $196.80M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $228.30M 10-K · filed 2018-02-26 |
| 2016-09-30 | $240.40M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $243.10M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $239.40M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $225.00M 10-K · filed 2017-02-28 |
| 2015-09-30 | $231.30M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $229.10M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $237.20M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $311.40M 10-K · filed 2016-02-26 |
| 2014-09-30 | $320.70M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $359.20M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $387.80M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $365.80M 10-K · filed 2015-02-25 |
| 2013-09-30 | $383.50M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $400.10M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $435.30M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $386.00M 10-K · filed 2014-02-27 |
| 2012-09-30 | $364.70M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $299.30M 10-Q · filed 2012-08-06 |
| 2011-12-31 | $279.20M 10-K · filed 2013-02-27 |
| 2011-09-30 | $302.70M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $361.40M 10-Q/A · filed 2011-08-08 |
| 2010-12-31 | $344.20M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |